# Comparison of Dexmedetomidine and Remifentanil Infusion During CABG

> **NCT01572454** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 77 (actual)

## Conditions studied

- Coronary Artery Bypass Graft
- Hypokalemia
- Cardiac Arrhythmia
- Dexmedetomidine
- Remifentanil

## Interventions

- **DRUG:** Dexmedetomidine infusion
- **DRUG:** Remifentanil infusion

## Key facts

- **NCT ID:** NCT01572454
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2013-12-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572454, "Comparison of Dexmedetomidine and Remifentanil Infusion During CABG". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01572454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*